Regorafenib: from bench to bedside in colorectal cancer

By Shahda Safi   Saif Muhammad Wasif  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 3, 2013-05 ,pp. : 243-248

Informa Healthcare

Access to resources Recommend Favorite

Risk of hypertension with regorafenib in cancer patients: a systematic review and meta-analysis

By Wang Zexing   Xu Jing   Nie Weiwei   Huang Guichun   Tang Jinhai   Guan Xiaoxiang  

European Journal of Clinical Pharmacology, Vol. 70, Iss. 2, 2014-02 ,pp. : 225-231

Springer Publishing Company

Access to resources Recommend Favorite

Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

By Sunakawa Yu   Furuse Junji   Okusaka Takuji   Ikeda Masafumi   Nagashima Fumio   Ueno Hideki   Mitsunaga Shuichi   Hashizume Kensei   Ito Yuichiro   Sasaki Yasutsuna  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 388-388

Springer Publishing Company

Access to resources Recommend Favorite

The Complexity of Cancer

By Wright Tracey  

Pharmaceutical & Diagnostic Innovation, Vol. 4, Iss. 8, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Cancer vaccines

By Bonnefoy Jean-Yves  

Expert Opinion on Therapeutic Targets, Vol. 8, Iss. 6, 2004-12 ,pp. : 521-525

Informa Healthcare

Access to resources Recommend Favorite